ArticleFrontiers in nutrition2026
Body composition phenotypes and phase angle as predictors of mortality in subjects with right ventricular dysfunction: a prospective cohort study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Right ventricular dysfunction (RVD) is characterized by abnormal RV structure or function and is associated with worse outcomes. In subjects with RVD, cardiac cachexia and sarcopenia were associated with intestinal congestion. However, the prognostic impact and prevalence of body composition phenotypes and phase angle (PhA) in RVD have been insufficiently studied. Objective: To assess the prognostic impact and prevalence of body composition phenotypes and PhA in RVD. Methods: A prospective cohort study was conducted. Outpatient subjects over 18 years old with a confirmed diagnosis of RVD were included. Dynapenia, muscle wasting, and sarcopenia, according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), while cachexia was defined according to Evans criteria. Results: A total of 212 subjects with RVD were included. The mean age of the subjects was 64.47 ± 13.99 years, and 58.96% were men. The prevalence of dynapenia was 28.30%, muscle wasting was 10.38, sarcopenia was 21.70%, and cachexia was 4.25%. The independent risk factors for mortality were PhA < 5° (HR: 2.29, 95% CI: 1.27 to 4.15, Conclusion: In subjects with RVD, there is a higher prevalence of muscle disorders such as dynapenia, sarcopenia, and cachexia. Besides PhA, sarcopenia and cachexia were associated with a worse prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.